论文部分内容阅读
目的探讨Rho激酶抑制剂盐酸法舒地尔注射液治疗急性脑梗死的临床效果。方法采用法舒地尔注射液30mg静脉滴注,2次/天,共用2个疗程,7天为1个疗程,剂量可根据病情、体重、体质情况及溶栓效果等情况作调整。结果在治疗前及治疗第1-2个疗程后分别进行观察、记录;对患者临床神经功能缺损程度及病残程度进行评分判断。同时检测血常规、纤维蛋白原、出血时间和凝血时间以及肝、肾功能等。结论盐酸法舒地尔作为一种新型的神经保护剂,治疗急性脑梗死是安全有效的。
Objective To investigate the clinical efficacy of Rho kinase inhibitor fasudil hydrochloride injection in the treatment of acute cerebral infarction. Methods Fasudil injection 30mg intravenously, 2 times / day, sharing 2 courses, 7 days for a course of treatment, the dose can be adjusted according to the condition, weight, physical condition and thrombolytic effect. Results Before treatment and after treatment for the first two courses of treatment were observed and recorded; the degree of clinical neurological deficit and degree of sickness to judge the score. At the same time detection of blood, fibrinogen, bleeding time and clotting time and liver and kidney function. Conclusion Fasudil hydrochloride is a new neuroprotective agent that is safe and effective in the treatment of acute cerebral infarction.